Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 670 | 683 | 854 | 854 | 896 |
| Gross Profit | 670 | 683 | 854 | 854 | 896 |
| Operating Expenses | 12,010 | 9,253 | 11,477 | 9,623 | 12,050 |
| Operating Income | -11,340 | -8,570 | -10,623 | -8,769 | -11,154 |
| Interest Expense | 234 | 233 | 233 | 239 | 311 |
| Other Income | -4 | 1,782 | 1,907 | -120 | 10,142 |
| Pre-tax Income | -11,578 | -7,021 | -8,949 | -9,128 | -1,323 |
| Net Income Continuous | -11,578 | -7,021 | -8,949 | -9,128 | -1,323 |
| Net Income | $-11,578 | $-7,021 | $-8,949 | $-9,128 | $-1,323 |
| EPS Basic Total Ops | -33.61 | -19.60 | -25.20 | -27.30 | -1.43 |
| EPS Basic Continuous Ops | -31.64 | -19.72 | -25.91 | -28.33 | -1.83 |
| EPS Diluted Total Ops | -27.31 | -19.60 | -31.50 | -27.30 | -10.88 |
| EPS Diluted Continuous Ops | -31.64 | -19.72 | -25.91 | -28.33 | 0.63 |
| EBITDA(a) | $-11,308 | $-8,537 | $-10,581 | $-8,714 | $-11,076 |